Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective studyA G Bostom, D Shemin, P Verhoef, et al.Advances in Renal Replacement Therapy|October 29, 2000
First hemodialysis access selection varies with patient acuityA L Friedman, C Walworth, C Meehan, et al.Kidney International|February 1, 1983
Secondary hypocapnia fails to protect "whole body" intracellular pH during chronic HCl-acidosis in the dogD D Clark, B S Chang, S G Garella, et al.Acta Crystallographica. Section D, Biological Crystallography|February 27, 2001
Crystallization and preliminary X-ray analysis of a NADPH 2-ketopropyl-coenzyme M oxidoreductase/carboxylaseS B Jang, M S Jeong, D D Clark, et al.Journal of Medical Entomology|November 1, 1994
Landscape patterns of abundance of Ixodes scapularis (Acari: Ixodidae) on Shelter Island, New YorkD C Duffy, D D Clark, S R Campbell, et al.Circulation|June 22, 2000
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patientsA G Bostom, D Shemin, P Bagley, et al.Kidney International. Supplement|February 13, 2001
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipientsA G Bostom, D Shemin, R Y Gohh, et al.Kidney International|January 1, 1996
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patientsA G Bostom, D Shemin, K L Lapane, et al.Atherosclerosis|April 7, 1995
Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control studyA G Bostom, D Shemin, K L Lapane, et al.Atherosclerosis|June 1, 1996
Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patientsA G Bostom, D Shemin, K L Lapane, et al.Pageof 7